CCL28 and type 2 diabetes mellitus: As CCL28 at the higher doses observed in T2DM may induce signaling in non-endothelial cells in the wound environment via CCR10 as well as CCR3 receptors, we sought to assess the effect of CCL28 overexpression in WT mice as well as CCL28 neutralization in diabetic skin wounds with a specific antibody (Ab).